Retatrutide
An experimental Eli Lilly weight-loss drug hitting three gut-hormone receptors at once. In real trials it produced eye-watering fat loss — which is exactly why the grey market is selling unapproved copies of it.
What people claim
Dramatic weight loss beyond current GLP-1 drugs; the 'next Ozempic,' but bigger.
Human evidence
This is the rare peptide with genuine, high-quality human data: Lilly's phase 2 trial (published in the New England Journal of Medicine) showed some of the largest average weight reductions seen from a drug. Phase 3 trials are ongoing. That evidence is for Lilly's actual drug under medical supervision — not for grey-market vials.
Animal evidence
Standard preclinical work supported moving it into humans; the human trials are what matter here.
Risk flags
- Unregulated / grey-market supply
- Purity & quality unknowable
- Long-term effects unknown
- Cardiovascular effects unclear
- Legal grey area (US/UK)
Regulatory status
US: Investigational. NOT FDA-approved — still in trials as of 2026. Any 'retatrutide' sold online is unapproved and not the studied product.
UK: Investigational; no MHRA authorisation. Not available as a licensed medicine.
What people report
Typical reported ranges — reporting, not a recommendation
Unlike most peptides, the numbers here come from a real trial: Lilly's phase 2 study tested escalating monthly-titrated doses up to 12 mg weekly, with slow dose-escalation to manage nausea.
Those doses were used under medical supervision with a pharmaceutical-grade product and careful titration — not something to replicate from a grey-market vial of unknown identity. The trial number is a citation, not an instruction.
Everyone's an expert
Who says what
Gym Bros Say
"Reta makes Ozempic look like a warm-up. People are dropping serious weight — but it's not out yet, so everyone's buying the grey stuff."
Clinics Say
Reputable clinics can't prescribe it yet — it isn't approved. Anyone offering 'retatrutide therapy' now is operating ahead of the regulators.
Reddit Says
Huge hype in weight-loss and biohacking subs, plus a strong 'this one's actually backed by NEJM data' faction — and constant, valid warnings that grey-market vials aren't the trial drug.
Big Pharma Says
Lilly is running large phase 3 trials and will seek approval. This is the legitimate future-of-metabolic-medicine story — via the medical system, not a vial from a chat group.
Science Actually Says
Grade B and rising: real, published, large human trials showing major weight loss. The catch — that evidence applies to the supervised, approved-pathway drug, not to unregulated copies of unknown identity or purity.
Doc Says
In the published phase-2 trial (NEJM, 2023), retatrutide was escalated slowly to weekly doses of up to ~12 mg under close medical monitoring — that's where the headline weight loss came from. But it isn't approved, so no clinician can legitimately prescribe it yet. Reported from the trial, not a recommendation.
PeptideStackers Says
The peptide that proves the category deserves to be taken seriously. Also the clearest case for waiting for the real, approved thing: never has 'the data is great' and 'don't buy this online' both been so true at once.
Honesty section
What we still don't know
- ?Full long-term safety — phase 3 and post-marketing data aren't in yet.
- ?Cardiovascular and other long-horizon effects at scale.
- ?Whether any grey-market 'retatrutide' is even the correct molecule at a real concentration.
Real questions people ask
FAQ
- Is retatrutide the same as Ozempic?
- No. Ozempic (semaglutide) hits one receptor; retatrutide hits three. Retatrutide isn't approved yet, while semaglutide and tirzepatide are prescribable medicines.
- Where can you get retatrutide?
- Legitimately, you can't yet — it's still in trials. That's the honest answer. Grey-market vials are unapproved products of unknown identity; we don't point you to sources. See why supplier reviews are hard to trust.
- Is retatrutide safe?
- The trial data so far is encouraging on efficacy, but long-term safety is still being established in phase 3. 'Promising in a monitored trial' is not the same as 'safe to self-administer from an unregulated vial.'
Before you do anything
Questions to ask a qualified professional
- 01Is there an approved GLP-1 medicine that fits my situation right now, prescribed and monitored?
- 02Do I understand that unapproved 'reta' is not the drug from the trials?
- 03What monitoring would a doctor want for any drug this powerful?
Related
Sources
Last reviewed: 2026-07-07